BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum. 2010;53:1692-1698. [PMID: 21178866 DOI: 10.1007/dcr.0b013e3181f42b89] [Cited by in Crossref: 226] [Cited by in F6Publishing: 69] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Walker AS, Zwintscher NP, Johnson EK, Maykel JA, Stojadinovic A, Nissan A, Avital I, Brücher BL, Steele SR. Future directions for monitoring treatment response in colorectal cancer. J Cancer 2014;5:44-57. [PMID: 24396497 DOI: 10.7150/jca.7809] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
2 Song JH, Park YH, Seo SH, Lee A, Kim KH, An MS, Bae KB, Hong KH, Hwang JW, Kim JH, Jung HS, Ahn KJ. Difference in Tumor Area as a Predictor of a Pathological Complete Response for Patients With Locally Advanced Rectal Cancer. Ann Coloproctol 2017;33:219-26. [PMID: 29354604 DOI: 10.3393/ac.2017.33.6.219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Zhang S, Zhang R, Li RZ, Wang QX, Chang H, Ding PR, Li LR, Wu XJ, Chen G, Zeng ZF, Xiao WW, Gao YH. Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Sci 2021;112:3607-15. [PMID: 34146368 DOI: 10.1111/cas.15039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Barina A, De Paoli A, Delrio P, Guerrieri M, Muratore A, Bianco F, Vespa D, Asteria C, Morpurgo E, Restivo A, Coco C, Pace U, Belluco C, Aschele C, Lonardi S, Valentini V, Mantello G, Maretto I, Del Bianco P, Perin A, Pucciarelli S. Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study. Tech Coloproctol 2017;21:633-40. [PMID: 28755256 DOI: 10.1007/s10151-017-1665-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
5 Landi F, Espín E, Rodrigues V, Vallribera F, Martinez A, Charpy C, Brunetti F, Azoulay D, de'Angelis N. Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy. Int J Colorectal Dis 2017;32:255-64. [PMID: 27757541 DOI: 10.1007/s00384-016-2685-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
6 Cheong C, Shin JS, Suh KW. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer. World J Gastroenterol 2020; 26(44): 7022-7035 [PMID: 33311947 DOI: 10.3748/wjg.v26.i44.7022] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lim SG, Kim YB, Oh SY. Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer. World J Surg 2016;40:3029-34. [PMID: 27464916 DOI: 10.1007/s00268-016-3661-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
8 Habr-Gama A, Perez RO. No Surgery After Chemoradiation Is Not Equal to Nonoperative Management After Complete Clinical Response and Chemoradiation. J Clin Oncol 2016;34:4051. [PMID: 27528720 DOI: 10.1200/JCO.2016.67.9001] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Cerdán-santacruz C, Vailati BB, São Julião GP, Habr-gama A, Pérez RO. Watch and wait: Why, to whom and how. Surgical Oncology 2022. [DOI: 10.1016/j.suronc.2022.101774] [Reference Citation Analysis]
10 Ghiselli R, Ortenzi M, Cardinali L, Skrami E, Gesuita R, Guerrieri M. Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy. Surg Endosc. 2017;31:2997-3003. [PMID: 27837319 DOI: 10.1007/s00464-016-5321-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Jung S, Parajuli A, Yu CS, Park SH, Lee JS, Kim AY, Lee JL, Kim CW, Yoon YS, Park IJ, Lim SB, Kim JC. Sensitivity of Various Evaluating Modalities for Predicting a Pathologic Complete Response After Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer. Ann Coloproctol 2019;35:275-81. [PMID: 31726004 DOI: 10.3393/ac.2019.01.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Peacock O, Chang GJ. "Watch and Wait" for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer. Minerva Chir 2019;74:481-95. [PMID: 31580047 DOI: 10.23736/S0026-4733.19.08184-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Carchman E, Chu DI, Kennedy GD, Morris M, Dakermandji M, Monson JRT, Fernandez LM, Perez RO, Fichera A, Allaix ME, Liska D. SSAT State-of-the-Art Conference: Advances in the Management of Rectal Cancer. J Gastrointest Surg 2019;23:433-42. [PMID: 30215203 DOI: 10.1007/s11605-018-3965-9] [Reference Citation Analysis]
14 Yeo SG, Kim DY, Oh JH. Long-term survival without surgery following a complete response to pre-operative chemoradiotherapy for rectal cancer: A case series. Oncol Lett 2013;6:1573-6. [PMID: 24260048 DOI: 10.3892/ol.2013.1596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Vailati BB, São Julião GP, Habr-gama A, Perez RO. Nonoperative Management of Rectal Cancer. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2021.11.003] [Reference Citation Analysis]
16 De Palma FDE, Luglio G, Tropeano FP, Pagano G, D'Armiento M, Kroemer G, Maiuri MC, De Palma GD. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. Int J Mol Sci 2020;21:E7040. [PMID: 32987896 DOI: 10.3390/ijms21197040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ortega CD, Perez RO. Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer. Insights Imaging 2019;10:59. [PMID: 31147789 DOI: 10.1186/s13244-019-0742-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Tang JH, An X, Lin X, Gao YH, Liu GC, Kong LH, Pan ZZ, Ding PR. The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Oncotarget 2015;6:33919-25. [PMID: 26416245 DOI: 10.18632/oncotarget.5287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
19 Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Fernandez LM, Figueiredo MN, Gama-Rodrigues J, Buchpiguel CA. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen. Radiat Oncol 2016;11:24. [PMID: 26911200 DOI: 10.1186/s13014-016-0598-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
20 Rödel C, Fokas E, Gani C. Complete response after chemoradiotherapy for rectal cancer: what is the reasonable approach? Innov Surg Sci 2018;3:47-53. [PMID: 31579765 DOI: 10.1515/iss-2017-0041] [Reference Citation Analysis]
21 Santos MD, Silva C, Rocha A, Matos E, Nogueira C, Lopes C. Tumor regression grades: can they influence rectal cancer therapy decision tree? Int J Surg Oncol. 2013;2013:572149. [PMID: 24187617 DOI: 10.1155/2013/572149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
22 Glimelius B. Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer? Front Oncol. 2014;4:50. [PMID: 24778990 DOI: 10.3389/fonc.2014.00050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
23 Vignali A, Nardi PD. Multidisciplinary treatment of rectal cancer in 2014: Where are we going? World J Gastroenterol 2014; 20(32): 11249-11261 [PMID: 25170209 DOI: 10.3748/wjg.v20.i32.11249] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
24 Pozo ME, Fang SH. Watch and wait approach to rectal cancer: A review. World J Gastrointest Surg 2015; 7(11): 306-312 [PMID: 26649153 DOI: 10.4240/wjgs.v7.i11.306] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
25 Maas M, Lambregts DM, Nelemans PJ, Heijnen LA, Martens MH, Leijtens JW, Sosef M, Hulsewé KW, Hoff C, Breukink SO, Stassen L, Beets-Tan RG, Beets GL. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol 2015;22:3873-80. [PMID: 26198074 DOI: 10.1245/s10434-015-4687-9] [Cited by in Crossref: 148] [Cited by in F6Publishing: 117] [Article Influence: 21.1] [Reference Citation Analysis]
26 Custers PA, Geubels BM, Huibregtse IL, Peters FP, Engelhardt EG, Beets GL, Marijnen CAM, van Leerdam ME, van Triest B. Contact X-ray Brachytherapy for Older or Inoperable Rectal Cancer Patients: Short-Term Oncological and Functional Follow-Up. Cancers (Basel) 2021;13:6333. [PMID: 34944953 DOI: 10.3390/cancers13246333] [Reference Citation Analysis]
27 Zhang PB, Huang ZL, Li JB, Huang XY. A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy. Cancer Manag Res 2019;11:10801-6. [PMID: 31920389 DOI: 10.2147/CMAR.S225628] [Reference Citation Analysis]
28 Han KS, Sohn DK, Kim DY, Kim BC, Hong CW, Chang HJ, Kim SY, Baek JY, Park SC, Kim MJ, Oh JH. Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer. Cancer Res Treat 2016;48:567-73. [PMID: 26511812 DOI: 10.4143/crt.2015.195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
29 Blažić I, Maksimović R, Gajić M, Šaranović Đ. Apparent diffusion coefficient measurement covering complete tumor area better predicts rectal cancer response to neoadjuvant chemoradiotherapy. Croat Med J 2015;56:460-9. [PMID: 26526883 DOI: 10.3325/cmj.2015.56.460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
30 Thien HH, Hiep PN, Thanh PH, Xuan NT, Trung TN, Vy PT, Dong PX, Hieu MT, Son NH. Transanal total mesorectal excision for locally advanced middle-low rectal cancers. BJS Open 2020;4:268-73. [PMID: 32207572 DOI: 10.1002/bjs5.50234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kleiman A, Al-Khamis A, Farsi A, Kezouh A, Vuong T, Gordon PH, Vasilevsky CA, Morin N, Faria J, Ghitulescu G, Boutros M. Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer. J Gastrointest Surg. 2015;19:1106-1112. [PMID: 25859755 DOI: 10.1007/s11605-015-2814-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
32 Habr-Gama A, São Julião GP, Vailati BB, Castro I, Raffaele D. Management of the Complete Clinical Response. Clin Colon Rectal Surg 2017;30:387-94. [PMID: 29184475 DOI: 10.1055/s-0037-1606116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
33 Ko HM, Choi YH, Lee JE, Lee KH, Kim JY, Kim JS. Combination Assessment of Clinical Complete Response of Patients With Rectal Cancer Following Chemoradiotherapy With Endoscopy and Magnetic Resonance Imaging. Ann Coloproctol. 2019;35:202-208. [PMID: 31487768 DOI: 10.3393/ac.2018.10.15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
34 Greer JB, Hawkins AT. Non-operative management of rectal cancer. Semin Colon Rectal Surg 2019;30:79-84. [PMID: 32818013 DOI: 10.1053/j.scrs.2019.04.007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, Guillem JG, Paty PB, Yaeger R, Stadler ZK, Seier K, Gonen M, Segal NH, Reidy DL, Varghese A, Shia J, Vakiani E, Wu AJ, Crane CH, Gollub MJ, Garcia-Aguilar J, Saltz LB, Weiser MR. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 2018;4:e180071. [PMID: 29566109 DOI: 10.1001/jamaoncol.2018.0071] [Cited by in Crossref: 151] [Cited by in F6Publishing: 127] [Article Influence: 37.8] [Reference Citation Analysis]
36 de Azevedo JM, Vailati BB, Julião GPS, Fernandez LM, Perez RO. Current Surgical Strategies in the Management of Rectal Cancer. Curr Colorectal Cancer Rep 2019;15:18-27. [DOI: 10.1007/s11888-019-00428-0] [Reference Citation Analysis]
37 Chavda V, Siaw O, Chaudhri S, Runau F. Management of early rectal cancer; current surgical options and future direction. World J Gastrointest Surg 2021; 13(7): 655-667 [PMID: 34354799 DOI: 10.4240/wjgs.v13.i7.655] [Reference Citation Analysis]
38 Wang QX, Zhang R, Xiao WW, Zhang S, Wei MB, Li YH, Chang H, Xie WH, Li LR, Ding PR, Chen G, Zeng ZF, Wang WH, Wan XB, Gao YH. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy. Radiat Oncol 2021;16:16. [PMID: 33468176 DOI: 10.1186/s13014-021-01746-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. Curr Colorectal Cancer Rep. 2018;14:37-55. [PMID: 29576755 DOI: 10.1007/s11888-018-0398-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
40 Kim JK, Thompson H, Jimenez-Rodriguez RM, Wu F, Sanchez-Vega F, Nash GM, Guillem JG, Paty PB, Wei IH, Pappou EP, Widmar M, Weiser MR, Smith JJ, Garcia-Aguilar J. Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival. Ann Surg Oncol 2021. [PMID: 34601641 DOI: 10.1245/s10434-021-10877-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Felder SI, Patil S, Kennedy E, Garcia-Aguilar J. Endoscopic Feature and Response Reproducibility in Tumor Assessment after Neoadjuvant Therapy for Rectal Adenocarcinoma. Ann Surg Oncol 2021;28:5205-23. [PMID: 33796995 DOI: 10.1245/s10434-021-09827-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Leow YC, Roslani AC, Xavier RG, Lee FY. Pathological Complete Response After Neoadjuvant Therapy in Rectal Adenocarcinoma: a 5-Year Follow-up. Indian J Surg 2021;:1-8. [PMID: 34075282 DOI: 10.1007/s12262-021-02945-5] [Reference Citation Analysis]
43 Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer.Nat Rev Gastroenterol Hepatol. 2020;17:414-429. [PMID: 32203400 DOI: 10.1038/s41575-020-0275-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
44 Chiloiro G, Cusumano D, de Franco P, Lenkowicz J, Boldrini L, Carano D, Barbaro B, Corvari B, Dinapoli N, Giraffa M, Meldolesi E, Manfredi R, Valentini V, Gambacorta MA. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development. Radiol Med 2021. [PMID: 34725772 DOI: 10.1007/s11547-021-01421-0] [Reference Citation Analysis]
45 Martens MH, Lambregts DM, Papanikolaou N, Alefantinou S, Maas M, Manikis GC, Marias K, Riedl RG, Beets GL, Beets-Tan RG. Magnetization transfer imaging to assess tumour response after chemoradiotherapy in rectal cancer. Eur Radiol 2016;26:390-7. [PMID: 26065396 DOI: 10.1007/s00330-015-3856-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
46 Tez M. Re: "Usefulness of Endoscopic Tattooing Before Neoadjuvant Therapy in Patients with Clinical Complete Response in Locally Advanced Rectal Cancer for Providing a Safe Distal Surgical Margin" by Yigit et al. J Laparoendosc Adv Surg Tech A 2021;31:1321. [PMID: 34619051 DOI: 10.1089/lap.2021.0535] [Reference Citation Analysis]
47 Habr-Gama A, Gama-Rodrigues J, Perez RO. In reply to Sole and Calvo. Int J Radiat Oncol Biol Phys 2014;89:933-4. [PMID: 24969808 DOI: 10.1016/j.ijrobp.2014.04.005] [Reference Citation Analysis]
48 Gani C, Bonomo P, Zwirner K, Schroeder C, Menegakis A, Rödel C, Zips D. Organ preservation in rectal cancer - Challenges and future strategies. Clin Transl Radiat Oncol 2017;3:9-15. [PMID: 29658007 DOI: 10.1016/j.ctro.2017.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
49 López-Campos F, Martín-Martín M, Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R, López-Durán S, Domínguez-Rullán J, Ferreiro R, Riquelme-Oliveira A, Hervás-Morón A, Couñago F. Watch and wait approach in rectal cancer: Current controversies and future directions. World J Gastroenterol 2020; 26(29): 4218-4239 [PMID: 32848330 DOI: 10.3748/wjg.v26.i29.4218] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
50 Xiao L, Yu X, Deng W, Feng H, Chang H, Xiao W, Zhang H, Xi S, Liu M, Zhu Y, Gao Y. Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy. Sci Rep. 2016;6:34923. [PMID: 27721486 DOI: 10.1038/srep34923] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
51 Glimelius B. Neo-adjuvant radiotherapy in rectal cancer. World J Gastroenterol 2013; 19(46): 8489-8501 [PMID: 24379566 DOI: 10.3748/wjg.v19.i46.8489] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
52 Biondo S, Fraccalvieri D, Golda T, Frago R, Trenti L, Kreisler E. Update on advances and controversy in rectal cancer treatment. Tech Coloproctol 2016;20:145-52. [PMID: 26754651 DOI: 10.1007/s10151-015-1418-y] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
53 Kastner C, Petritsch B, Reibetanz J, Germer CT, Wiegering A. [Complete response after neoadjuvant therapy of rectal cancer: implications for surgery]. Chirurg 2021. [PMID: 34878582 DOI: 10.1007/s00104-021-01540-4] [Reference Citation Analysis]
54 Melotti G, De Antoni E, Habr-Gama A, Minicozzi A. Management of distal rectal cancer: results from a national survey. Updates Surg 2013;65:43-52. [PMID: 23335049 DOI: 10.1007/s13304-012-0192-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
55 Carpinetti P, Donnard E, Bettoni F, Asprino P, Koyama F, Rozanski A, Sabbaga J, Habr-Gama A, Parmigiani RB, Galante PA, Perez RO, Camargo AA. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation. Oncotarget 2015;6:38360-71. [PMID: 26451609 DOI: 10.18632/oncotarget.5256] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
56 González JEB, Lavernia HC, Fraga JGP, Lemus SQ. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer. Surg Endosc 2021. [PMID: 34231071 DOI: 10.1007/s00464-021-08583-y] [Reference Citation Analysis]
57 Kokaine L, Gardovskis A, Gardovskis J. Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy. Medicina (Kaunas) 2021;57:1044. [PMID: 34684080 DOI: 10.3390/medicina57101044] [Reference Citation Analysis]
58 Smith FM, Wiland H, Mace A, Pai RK, Kalady MF. Assessment of a novel, full-thickness incisional biopsy model to restage rectal tumours after neoadjuvant chemoradiotherapy: results of an ex vivo pilot study. Tech Coloproctol 2015;19:159-64. [PMID: 25687376 DOI: 10.1007/s10151-015-1272-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
59 Lopez-Lopez V, Abrisqueta J, Lujan J, Hernandez Q, Ono A, Parrilla P. Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer. Saudi J Gastroenterol 2016;22:148-53. [PMID: 26997222 DOI: 10.4103/1319-3767.178526] [Reference Citation Analysis]
60 Mbanu P, Osorio EV, Mistry H, Malcomson L, Yousif S, Aznar M, Kochhar R, Van Herk M, Renehan A, Saunders M. Clinico-pathological predictors of clinical complete response in rectal cancer. Cancer Treatment and Research Communications 2022;31:100540. [DOI: 10.1016/j.ctarc.2022.100540] [Reference Citation Analysis]
61 Reibetanz J, Germer CT. [Restaging of rectal cancer with MRI and endoscopic ultrasound after neoadjuvant chemoradiotherapy]. Chirurg 2014;85:917. [PMID: 25234506 DOI: 10.1007/s00104-014-2889-5] [Reference Citation Analysis]
62 Chadi SA, Berho M, Wexner SD. Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature. Langenbecks Arch Surg 2015;400:661-73. [PMID: 26250144 DOI: 10.1007/s00423-015-1328-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
63 Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: Controversies and questions. World J Gastroenterol 2012; 18(39): 5521-5532 [PMID: 23112544 DOI: 10.3748/wjg.v18.i39.5521] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
64 Shi C, Zhang Y, Li Y, Geng J, Zhu X, Wang H, Cai Y, Wang W, Granito A. Hyperfractionation versus Conventional Fractionation of Preoperative Intensity-Modulated Radiotherapy with Oral Capecitabine in Locally Advanced Mid-Low Rectal Cancer: A Propensity Score Matching Study. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/9119245] [Reference Citation Analysis]
65 Leng X, Amidi E, Kou S, Cheema H, Otegbeye E, Chapman WJ, Mutch M, Zhu Q. Rectal Cancer Treatment Management: Deep-Learning Neural Network Based on Photoacoustic Microscopy Image Outperforms Histogram-Feature-Based Classification. Front Oncol 2021;11:715332. [PMID: 34631543 DOI: 10.3389/fonc.2021.715332] [Reference Citation Analysis]
66 Nacion AJD, Park YY, Yang SY, Kim NK. Critical and Challenging Issues in the Surgical Management of Low-Lying Rectal Cancer. Yonsei Med J 2018;59:703-16. [PMID: 29978607 DOI: 10.3349/ymj.2018.59.6.703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
67 Chapman WC Jr, Kim H, Bauer P, Makhdoom BA, Trikalinos NA, Pedersen KS, Glasgow SC, Mutch MG, Silviera ML, Roy A, Parikh PJ, Hunt SR. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy. Dis Colon Rectum 2022;65:198-206. [PMID: 34990423 DOI: 10.1097/DCR.0000000000001997] [Reference Citation Analysis]
68 Ferrari L, Fichera A. Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer.Gastroenterol Rep (Oxf). 2015;3:277-288. [PMID: 26290512 DOI: 10.1093/gastro/gov039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
69 Lopes-Ramos CM, Habr-Gama A, Quevedo Bde S, Felício NM, Bettoni F, Koyama FC, Asprino PF, Galante PA, Gama-Rodrigues J, Camargo AA. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Med Genomics. 2014;7:68. [PMID: 25496125 DOI: 10.1186/s12920-014-0068-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
70 On J, Aly EH. 'Watch and wait' in rectal cancer: summary of the current evidence. Int J Colorectal Dis 2018;33:1159-68. [PMID: 29978363 DOI: 10.1007/s00384-018-3116-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
71 Gollub MJ, Gultekin DH, Akin O, Do RK, Fuqua JL 3rd, Gonen M, Kuk D, Weiser M, Saltz L, Schrag D, Goodman K, Paty P, Guillem J, Nash GM, Temple L, Shia J, Schwartz LH. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol 2012;22:821-31. [PMID: 22101743 DOI: 10.1007/s00330-011-2321-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 9.4] [Reference Citation Analysis]
72 de Jong MC, van Dam RM, Maas M, Bemelmans MH, Olde Damink SW, Beets GL, Dejong CH. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. HPB (Oxford). 2011;13:745-752. [PMID: 21929676 DOI: 10.1111/j.1477-2574.2011.00372.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
73 Al-Sukhni E, Attwood K, Mattson DM, Gabriel E, Nurkin SJ. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Ann Surg Oncol. 2016;23:1177-1186. [PMID: 26668083 DOI: 10.1245/s10434-015-5017-y] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
74 Bitterman DS, Resende Salgado L, Moore HG, Sanfilippo NJ, Gu P, Hatzaras I, Du KL. Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer. Front Oncol 2015;5:286. [PMID: 26734570 DOI: 10.3389/fonc.2015.00286] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
75 Gollub MJ, Blazic I, Felder S, Knezevic A, Gonen M, Garcia-Aguilar J, Paty PP, Smith JJ. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer. Eur Radiol 2019;29:1104-13. [PMID: 30242504 DOI: 10.1007/s00330-018-5719-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
76 Varela C, Kim NK. Surgical Treatment of Low-Lying Rectal Cancer: Updates. Ann Coloproctol 2021;37:395-424. [PMID: 34961303 DOI: 10.3393/ac.2021.00927.0132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Arsoniadis EG, Finlayson E, Potenti F. Is there a role for specialized geriatric centers in treating geriatric cancer patients? Eur J Surg Oncol 2020;46:383-6. [PMID: 32005554 DOI: 10.1016/j.ejso.2019.12.012] [Reference Citation Analysis]
78 Lorenzon L, Evrard S, Beets G, Gonzalez-Moreno S, Kovacs T, D'Ugo D, Polom K; CORSiCA Study - EYSAC.1 Study Group. Global variation in the long-term outcomes of ypT0 rectal cancers. Eur J Surg Oncol 2020;46:420-8. [PMID: 31733929 DOI: 10.1016/j.ejso.2019.10.010] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Quezada-Diaz FF, Smith JJ. Nonoperative Management for Rectal Cancer. Hematol Oncol Clin North Am 2022:S0889-8588(22)00014-4. [PMID: 35562257 DOI: 10.1016/j.hoc.2022.03.003] [Reference Citation Analysis]
80 Qin Q, Wang L. Neoadjuvant therapy and subsequent treatment in rectal cancer: balance between oncological and functional outcomes. J Anus Rectum Colon 2018;2:47-58. [PMID: 31583321 DOI: 10.23922/jarc.2017-049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Neşşar G, Demirbağ AE, Mısırlıoğlu HC, Sezer S. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes. Turk J Gastroenterol 2019;30:951-6. [PMID: 31767549 DOI: 10.5152/tjg.2019.18984] [Reference Citation Analysis]
82 Yoo BC, Yeo SG. Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review. EPMA J 2017;8:61-7. [PMID: 28620444 DOI: 10.1007/s13167-017-0082-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
83 Neşşar G. Organ preservation in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy: Long-term results in three patients. Ulus Cerrahi Derg 2014;30:219-21. [PMID: 25931933 DOI: 10.5152/UCD.2014.2812] [Reference Citation Analysis]
84 Lu S, Liu Z, Wang B, Li F, Meng Y, Wang J, Wang Y, Wang H, Zhou X, Fu W. High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients. Cancer Cell Int 2021;21:205. [PMID: 33849545 DOI: 10.1186/s12935-021-01903-1] [Reference Citation Analysis]
85 Dunstan MJD, Rockall TA, Potter K, Stewart AJ. Radiological and clinical findings following rectal contact X-ray brachytherapy (Papillon technique) - how to assess response. J Contemp Brachytherapy 2018;10:179-89. [PMID: 29789768 DOI: 10.5114/jcb.2018.75605] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
86 Custers PA, Hupkens BJP, Grotenhuis BA, Kuhlmann KFD, Breukink SO, Beets GL, Melenhorst J, Beets‐tan RGH, Buijsen J, Festen S, de Graaf EJR, Haak HE, Hilling DE, Hoff C, Intven M, Komen N, Kusters M, van Leerdam ME, Peeters KCMJ, Peters FP, Pronk A, van der Sande ME, Schreurs WH, Sonneveld DJA, Talsma AK, Tuynman JB, Valkenburg‐van Iersel LBJ, Vermaas M, de Vos‐geelen J, van Westreenen HL, de Wilt JHW, Zimmerman DDE; the Dutch Watch‐and‐Wait Consortium (collaborators). Selected stage IV rectal cancer patients managed by the watch‐and‐wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery? Colorectal Disease. [DOI: 10.1111/codi.16034] [Reference Citation Analysis]
87 Li J, Li L, Yang L, Yuan J, Lv B, Yao Y, Xing S. Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Oncotarget. 2016;7:44857-44870. [PMID: 27070085 DOI: 10.18632/oncotarget.8622] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
88 Keller DS, Brown G. Invited editorial re: "Response assessment after (chemo) radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?". Eur J Surg Oncol 2019;45:929-30. [PMID: 30890283 DOI: 10.1016/j.ejso.2018.12.013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Alkan A, Hofving T, Angenete E, Yrlid U. Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients. Biomark Res 2021;9:60. [PMID: 34321074 DOI: 10.1186/s40364-021-00313-9] [Reference Citation Analysis]
90 Felder SI, Feuerlein S, Parsee A, Imanirad I, Sanchez J, Dessureault S, Kim R, Hoffe S, Frakes J, Costello J. Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples. Abdom Radiol (NY) 2021;46:1783-804. [PMID: 33111189 DOI: 10.1007/s00261-020-02827-6] [Reference Citation Analysis]
91 Solanki AA, Chang DT, Liauw SL. Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy. Onco Targets Ther. 2013;6:1097-1110. [PMID: 23983475 DOI: 10.2147/ott.s34869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
92 Smithson M, Irwin RK, Williams G, Mcleod MC, Choi EK, Ganguly A, Pepple A, Cho CS, Willey CD, Leopold J, Hardiman KM. Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer. Neoplasia 2022;25:53-61. [DOI: 10.1016/j.neo.2022.01.004] [Reference Citation Analysis]
93 Vojtíšek R, Korčáková E, Mařan J, Šorejs O, Fínek J. Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings. Rep Pract Oncol Radiother 2017;22:265-76. [PMID: 28507455 DOI: 10.1016/j.rpor.2017.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
94 Glynne-jones R, Hughes R. Current Status of the Watch-and-Wait Policy for Patients with Complete Clinical Response Following Neoadjuvant Chemoradiation in Rectal Cancer. Curr Colorectal Cancer Rep 2017;13:17-26. [DOI: 10.1007/s11888-017-0344-y] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Glimelius B. On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Ups J Med Sci 2017;122:1-10. [PMID: 28256956 DOI: 10.1080/03009734.2016.1274806] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
96 São Julião GP, Celentano JP, Alexandre FA, Vailati BB. Local Excision and Endoscopic Resections for Early Rectal Cancer. Clin Colon Rectal Surg 2017;30:313-23. [PMID: 29184466 DOI: 10.1055/s-0037-1606108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
97 Lynn PB, Strombom P, Garcia-Aguilar J. Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation. Clin Colon Rectal Surg 2017;30:395-403. [PMID: 29184476 DOI: 10.1055/s-0037-1606117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
98 Nardi PD, Carvello M. How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy? World J Gastroenterol 2013; 19(36): 5964-5972 [PMID: 24106396 DOI: 10.3748/wjg.v19.i36.5964] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]